BioAge Labs, Inc.
BIOA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $62 | $137 | $137 |
| - Cash | $354 | $22 | $28 |
| + Debt | $9 | $53 | $2 |
| Enterprise Value | -$284 | $168 | $111 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$69 | -$56 | -$39 |
| % Margin | – | – | – |
| Net Income | -$71 | -$64 | -$40 |
| % Margin | – | – | – |
| EPS Diluted | -6.63 | -8.55 | -5.32 |
| % Growth | 22.5% | -60.7% | – |
| Operating Cash Flow | -$52 | -$37 | -$36 |
| Capital Expenditures | -$0 | -$0 | -$0 |
| Free Cash Flow | -$52 | -$38 | -$36 |